Opinion

Video

Compounding Impact of TAS-102 and Bevacizumab in mCRC Treatment

Marwan G Fakih, MD, drives a discussion highlighting a significant combination therapy in mCRC treatment.

Related Videos
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, on data for neoadjuvant nivolumab plus ipilimumab in dMMR colon cancer.
Yair Lotan, MD, UT Southwestern Medical Center
Alex Herrera, MD
Bertram Yuh, MD, MISM, MSHCPM
5 KOLs are featured in this series.
5 KOLs are featured in this series.
Idoroenyi Amanam, MD